298 related articles for article (PubMed ID: 17160136)
1. The type III TGF-beta receptor suppresses breast cancer progression.
Dong M; How T; Kirkbride KC; Gordon KJ; Lee JD; Hempel N; Kelly P; Moeller BJ; Marks JR; Blobe GC
J Clin Invest; 2007 Jan; 117(1):206-17. PubMed ID: 17160136
[TBL] [Abstract][Full Text] [Related]
2. The type III TGF-beta receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-beta signaling.
Lee JD; Hempel N; Lee NY; Blobe GC
Carcinogenesis; 2010 Feb; 31(2):175-83. PubMed ID: 19955393
[TBL] [Abstract][Full Text] [Related]
3. Ectodomain shedding of TβRIII is required for TβRIII-mediated suppression of TGF-β signaling and breast cancer migration and invasion.
Elderbroom JL; Huang JJ; Gatza CE; Chen J; How T; Starr M; Nixon AB; Blobe GC
Mol Biol Cell; 2014 Aug; 25(16):2320-32. PubMed ID: 24966170
[TBL] [Abstract][Full Text] [Related]
4. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
Gordon KJ; Dong M; Chislock EM; Fields TA; Blobe GC
Carcinogenesis; 2008 Feb; 29(2):252-62. PubMed ID: 17999987
[TBL] [Abstract][Full Text] [Related]
5. TbetaRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity.
Finger EC; Turley RS; Dong M; How T; Fields TA; Blobe GC
Carcinogenesis; 2008 Mar; 29(3):528-35. PubMed ID: 18174241
[TBL] [Abstract][Full Text] [Related]
6. The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer.
Turley RS; Finger EC; Hempel N; How T; Fields TA; Blobe GC
Cancer Res; 2007 Feb; 67(3):1090-8. PubMed ID: 17283142
[TBL] [Abstract][Full Text] [Related]
7. Expression of the type III TGF-beta receptor is negatively regulated by TGF-beta.
Hempel N; How T; Cooper SJ; Green TR; Dong M; Copland JA; Wood CG; Blobe GC
Carcinogenesis; 2008 May; 29(5):905-12. PubMed ID: 18299279
[TBL] [Abstract][Full Text] [Related]
8. The balance of cell surface and soluble type III TGF-β receptor regulates BMP signaling in normal and cancerous mammary epithelial cells.
Gatza CE; Elderbroom JL; Oh SY; Starr MD; Nixon AB; Blobe GC
Neoplasia; 2014 Jun; 16(6):489-500. PubMed ID: 25077702
[TBL] [Abstract][Full Text] [Related]
9. Roles for the type III TGF-beta receptor in human cancer.
Gatza CE; Oh SY; Blobe GC
Cell Signal; 2010 Aug; 22(8):1163-74. PubMed ID: 20153821
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of the type III TGF-β receptor enhances metastasis and invasion in hepatocellullar carcinoma progression.
Zhang S; Sun WY; Wu JJ; Gu YJ; Wei W
Oncol Rep; 2016 Apr; 35(4):2373-81. PubMed ID: 26882862
[TBL] [Abstract][Full Text] [Related]
11. A tumor-promoting role for soluble TβRIII in glioblastoma.
Burghardt I; Schroeder JJ; Weiss T; Gramatzki D; Weller M
Mol Cell Biochem; 2021 Aug; 476(8):2963-2973. PubMed ID: 33772427
[TBL] [Abstract][Full Text] [Related]
12. Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth.
Gatza CE; Holtzhausen A; Kirkbride KC; Morton A; Gatza ML; Datto MB; Blobe GC
Neoplasia; 2011 Aug; 13(8):758-70. PubMed ID: 21847367
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer.
Jovanović B; Beeler JS; Pickup MW; Chytil A; Gorska AE; Ashby WJ; Lehmann BD; Zijlstra A; Pietenpol JA; Moses HL
Breast Cancer Res; 2014 Jul; 16(4):R69. PubMed ID: 24985072
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of the transforming growth factor-beta type III receptor impairs motility and invasion of metastatic cancer cells.
Criswell TL; Dumont N; Barnett JV; Arteaga CL
Cancer Res; 2008 Sep; 68(18):7304-12. PubMed ID: 18794117
[TBL] [Abstract][Full Text] [Related]
15. The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42.
Mythreye K; Blobe GC
Proc Natl Acad Sci U S A; 2009 May; 106(20):8221-6. PubMed ID: 19416857
[TBL] [Abstract][Full Text] [Related]
16. Increased type III TGF-β receptor shedding decreases tumorigenesis through induction of epithelial-to-mesenchymal transition.
Huang JJ; Corona AL; Dunn BP; Cai EM; Prakken JN; Blobe GC
Oncogene; 2019 May; 38(18):3402-3414. PubMed ID: 30643193
[TBL] [Abstract][Full Text] [Related]
17. TβRIII/β-arrestin2 regulates integrin α5β1 trafficking, function, and localization in epithelial cells.
Mythreye K; Knelson EH; Gatza CE; Gatza ML; Blobe GC
Oncogene; 2013 Mar; 32(11):1416-27. PubMed ID: 22562249
[TBL] [Abstract][Full Text] [Related]
18. The transforming growth factor-beta type III receptor mediates distinct subcellular trafficking and downstream signaling of activin-like kinase (ALK)3 and ALK6 receptors.
Lee NY; Kirkbride KC; Sheu RD; Blobe GC
Mol Biol Cell; 2009 Oct; 20(20):4362-70. PubMed ID: 19726563
[TBL] [Abstract][Full Text] [Related]
19. The type III transforming growth factor-β receptor inhibits proliferation, migration, and adhesion in human myeloma cells.
Lambert KE; Huang H; Mythreye K; Blobe GC
Mol Biol Cell; 2011 May; 22(9):1463-72. PubMed ID: 21411633
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic Ki-ras confers a more aggressive colon cancer phenotype through modification of transforming growth factor-beta receptor III.
Yan Z; Deng X; Friedman E
J Biol Chem; 2001 Jan; 276(2):1555-63. PubMed ID: 11029459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
